PharmaCorp Rx Inc. PCRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 141.16% | 86.08% | 110.79% | -81.73% | -55.99% |
| Total Receivables | 137.28% | 227.52% | 291.15% | 242.15% | 832.02% |
| Inventory | 77.47% | 93.89% | 116.20% | 625.68% | 3,049.75% |
| Prepaid Expenses | 134.30% | 200.00% | 76.65% | 183.23% | 168.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 131.90% | 90.69% | 115.21% | -69.93% | -45.35% |
|
|
|||||
| Total Current Assets | 131.90% | 90.69% | 115.21% | -69.93% | -45.35% |
| Net Property, Plant & Equipment | 31.06% | 40.29% | 42.91% | 351.09% | 399.55% |
| Long-term Investments | 42.80% | 67.00% | 70.07% | 603.58% | 1,893.12% |
| Goodwill | 42.80% | 67.00% | 70.07% | 603.58% | 1,893.12% |
| Total Other Intangibles | 127.00% | 133.87% | 137.13% | 297.15% | 456.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 74.71% | 83.44% | 95.43% | 20.06% | 46.35% |
|
|
|||||
| Total Accounts Payable | 64.83% | 70.18% | 255.40% | 459.79% | 391.72% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 244.69% | 270.01% | 282.56% | 222.50% | 14.76% |
| Total Finance Division Other Current Liabilities | -- | -86.33% | 524.66% | -- | 123.53% |
| Total Other Current Liabilities | -- | -86.33% | 524.66% | -- | 123.53% |
| Total Current Liabilities | 75.97% | 73.74% | 259.45% | 406.50% | 295.19% |
|
|
|||||
| Total Current Liabilities | 75.97% | 73.74% | 259.45% | 406.50% | 295.19% |
| Long-Term Debt | 944.68% | 956.02% | 918.58% | 805.21% | -20.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 78.79% | 91.09% | 97.07% | 30.72% | 9.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.54% | 67.38% | 70.89% | 327.80% | 471.28% |
| Total Liabilities | 117.46% | 129.79% | 200.62% | 358.38% | 195.91% |
|
|
|||||
| Common Stock & APIC | 57.29% | 68.64% | 71.68% | -3.09% | 34.03% |
| Retained Earnings | -3.91% | -57.23% | -62.73% | 9.62% | -20.11% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.82% | 76.40% | 79.56% | -2.48% | 35.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.82% | 76.40% | 79.56% | -2.48% | 35.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 61.99% | 89.29% | 64.17% | -10.38% | 50.40% |
| Total Equity | 67.77% | 76.50% | 79.45% | -2.55% | 35.26% |
|
|
|||||